Epileptic encephalopathy
Not recruitingTitle: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies
Title: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies
- Disease:Epileptic encephalopathy
- Substances:Bexicaserin hydrochloride
Belgium- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Bexicaserin hydrochloride
- Sponsor:Longboard Pharmaceuticals Inc.








